Creative Planning
BPMC

Creative Planning’s Blueprint Medicines BPMC Stock Holding History

Creative Planning’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-32,810
Closed -$4.21M – 3926
2025
Q2 		$4.21M Buy
32,810
+11,745
+56% +$1.22M ﹤0.01% 843
2025
Q1 		$1.86M Buy
21,065
+1,584
+8% +$155K ﹤0.01% 1217
2024
Q4 		$1.7M Buy
19,481
+6,287
+48% +$576K ﹤0.01% 1242
2024
Q3 		$1.22M Buy
13,194
+843
+7% +$83.7K ﹤0.01% 1368
2024
Q2 		$1.33M Buy
12,351
+2,636
+27% +$264K ﹤0.01% 1219
2024
Q1 		$922K Buy
9,715
+2,888
+42% +$248K ﹤0.01% 1388
2023
Q4 		$630K Buy
6,827
+6,727
+6,727% +$436K ﹤0.01% 1535
2023
Q3 		$5.02K Buy
+100
New +$5.34K ﹤0.01% 2718
2017
Q3 		– Sell
-100
Closed -$5K – 2112
2017
Q2 		$5K Sell
100
-500
-83% -$21.2K ﹤0.01% 3969
2017
Q1 		$24K Buy
600
+500
+500% +$17.9K ﹤0.01% 2996
2016
Q4 		$3K Hold
100
– – ﹤0.01% 4130
2016
Q3 		$3K Hold
100
– – ﹤0.01% 4068
2016
Q2 		$2K Hold
100
– – ﹤0.01% 3983
2016
Q1 		$2K Hold
100
– – ﹤0.01% 3922
2015
Q4 		$3K Hold
100
– – ﹤0.01% 3887
2015
Q3 		$2K Buy
+100
New +$2.77K ﹤0.01% 3917

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Creative Planning's BPMC Position: Q3 2025 in Review

Creative Planning sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 32,810 shares — an estimated $4.21M sold.

Creative Planning first reported a position in BPMC in Q3 2015 and held it in 16 quarters. The position peaked at $4.21M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Creative Planning reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Creative Planning sold 32,810 Blueprint Medicines shares in Q3 2025, an estimated $4.21M.
  • Creative Planning first reported a position in Blueprint Medicines in Q3 2015 and held it in 16 quarters.
  • Creative Planning's Blueprint Medicines position peaked at $4.21M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Creative Planning's 13F filing for Q3 2025, filed 14 Nov 2025.